WATSON 3449 20 mg (Morphine Sulfate Extended Release 20 mg)
Pill with imprint WATSON 3449 20 mg is Yellow & White, Capsule-shape and has been identified as Morphine Sulfate Extended Release 20 mg. It is supplied by Watson Laboratories, Inc..
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 3449 20 mg
Morphine Sulfate Extended Release
- Imprint
- WATSON 3449 20 mg
- Strength
- 20 mg
- Color
- Yellow & White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3449
- Inactive Ingredients
-
corn starch,
diethyl phthalate,
ethylcelluloses,
polyethylene glycol 6000,
sucrose,
povidone k30,
magnesium silicate,
ferric oxide black,
gelatin,
propylene glycol,
titanium dioxide,
D&C Yellow No. 10,
hypromellose 2910 (5 mPa.s),
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.
More about morphine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 337 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (10)
Consumer resources
- Patient Information
- Morphine injection
- Morphine (Advanced Reading)
- Morphine Epidural (Advanced Reading)
- Morphine Injection (Advanced Reading)
- ... +6 more
- Other brands
- MS Contin, Roxanol, Kadian, Astramorph PF, ... +10 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.